KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) EPS (Basic) (2016 - 2025)

Pacific Biosciences Of California (PACB) has 16 years of EPS (Basic) data on record, last reported at -$0.13 in Q4 2025.

  • For Q4 2025, EPS (Basic) fell 750.0% year-over-year to -$0.13; the TTM value through Dec 2025 reached -$1.82, down 61.06%, while the annual FY2025 figure was -$1.82, 61.06% down from the prior year.
  • EPS (Basic) reached -$0.13 in Q4 2025 per PACB's latest filing, down from -$0.11 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.08 in Q3 2021 and bottomed at -$1.44 in Q1 2025.
  • Average EPS (Basic) over 5 years is -$0.32, with a median of -$0.3 recorded in 2024.
  • The widest YoY moves for EPS (Basic): up 157.14% in 2021, down 4600.0% in 2021.
  • A 5-year view of EPS (Basic) shows it stood at -$0.33 in 2021, then dropped by 12.12% to -$0.37 in 2022, then grew by 16.22% to -$0.31 in 2023, then surged by 106.45% to $0.02 in 2024, then crashed by 750.0% to -$0.13 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.13 in Q4 2025, -$0.11 in Q3 2025, and -$0.14 in Q2 2025.